FedTALLY

Awards for “BRISTOL-MYERS SQUIBB COMPANY

25 awards on this page · sorted by amount · page 2

Award IDRecipientAwarding agencyAmountStartEndNAICSDescription
36C24926F0059BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$335.04K
2025-12-152026-02-15325412BREYANZI FOR CAR T
36C24926N0232BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$335.04K
2025-10-272026-02-06325412BREYANZI CAR T THERAPY FOR TVHS TRANSPLANT CENTER
36C24925F0210BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$335.04K
2025-06-062025-08-08325412PURCHASE OF TRANSPLANT MEDICATION INJECTION.
36C24925F0143BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$335.04K
2025-03-132025-06-10325412TRANSPLANT BREYANZI CAR T
36C24925F0141BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$335.04K
2026-03-162026-03-16325412BREYANZI
36C24925F0133BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$335.04K
2025-03-142025-05-14325412PROCURING TRANSPLANT MEDICATION BREYANZI FOR VA PATIENT.
36C24925F0129BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$335.04K
2025-02-272025-05-28325412TRANSPLANT BREYANZI CAR T CELL
36C24925F0120BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$335.04K
2025-02-242025-03-02325412ANTINEOPLASTIC/ BCMA DIRECTED CAR-T CELL IMMUNOTHERAPY. QTY: 1, BREYANZI, 50-110M CAR POS T-CELL CTN US. LISOCABTAGENE MARALEUCEL APPROVED FOR A VETERAN PATIENT.
36C24925F0089BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$335.04K
2025-01-122026-01-11325412TRANSPLANT
36C26026F0137BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$327.53K
2026-01-152026-09-30325412MAVACAMTEN IS AN OUTPATIENT DRUG USED IN THE TREATMENT OF SPECIFIC TYPES OF CARDIOMYOPATHIES.
36C25923F0465BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$320.42K
2023-09-012023-10-01325412ABECMA
36C24925N0299BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2025-01-102025-03-09325412TRANSPLANT DRUG
36C24925N0286BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2025-01-032025-04-03325412ABECMA TRANSPLANT INJECTION
36C24925N0271BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2024-12-132025-02-12325412EMERGENCY EBECMA INJECTION
36C24925F0052BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2024-10-182024-11-30325412IDECABTAGENE VICLEUCEL/ABECMA INJECTION
36C24924N0523BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2024-06-102024-07-09325412ABECMA
36C24924N0470BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2024-05-152024-06-10325412ABECMA
36C24924N0412BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2024-03-202024-04-30325412IDECABTAGENE VICLEUCEL
36C24924N0409BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2024-04-022024-04-12325412QTY: 1, IDECABTAGENE VICLEUCEL INJ,SUSP (ABECMA) FOR ENR 015527
36C24924N0404BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2024-04-022024-04-05325412QTY: 1, IDECABTAGENE VICLEUCEL INJ,SUSP (ABECMA) FOR ENR 015588
36C24924N0323BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$314.32K
2024-03-012024-03-08325412EMERGENCY PHARMACEUTICAL ABECMA CAR T CELL THERAPY FOR TVHS
36C25924F0009BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$313.39K
2023-10-052023-10-17325412BREYANZI
36C25923F0317BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$313.39K
2023-05-262023-06-26325412BREYANZI
36C25923F0160BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$313.39K
2023-01-302023-03-07325412BREYANZI
36C25922F0224BRISTOL-MYERS SQUIBB COMPANYDepartment of Veterans Affairs$312.73K
2022-03-222022-04-19325412BREYANZI